Home › Kyphosis › New York › New York City
Kyphosis clinical trials in New York City, NY
4 studies for Kyphosis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery
RecruitingObservational study
- Columbia University - New York-Presbyterian Och Spine Hospital, New York
Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0
RecruitingObservational study
- Hospital for Special Surgery, Department of Orthopedic Surgery, New York
- New York University, Department of Orthopedic Surgery, New York
- Columbia University Medical Center, New York
Complex Adult Deformity Surgery (CADS)
RecruitingObservational study
- NYU, Department of Orthopedics, New York
- Hospital for Special Surgery, Department of Orthopedic Surgery, New York
- Columbia University Medical Center, New York
- and 1 more
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
RecruitingObservational study
- New York University, Department of Orthopedic Surgery, New York
Kyphosis trials in other cities
- Durham, NC4 studies
- San Diego, CA4 studies
- San Francisco, CA3 studies
- Shreveport, LA3 studies
- Charlottesville, VA3 studies
- Denver, CO3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.